IGHE and asthma: Anti-human extra-membrane proximal domain (EMPD) antibodies proved efficient in vivo, targeting humanized mouse (Figure 2), or human PBMC, by promoting apoptosis, decreasing IgE PC number, and lowering IgE production in models of asthma induction and helminth infection (71).